Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live

Canada & Moderna

9 shared events · Importance 5 · Last updated Aug 23, 2026

Importance
5
Shared Events
9
Actions
4
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
60
International
Canada: Canada>>> has imposed a 90-day entry ban on residents from the Democratic Republic of the Congo>>>, Uganda>>>, and South Sudan>>> due to concerns about the Ebola outbreak.
Moderna: Moderna is utilizing its mRNA technology to develop a vaccine for the Bundibugyo strain of Ebola, with funding from CEPI, aiming to rapidly train the body to fight the virus.
May 21, 2026 · 627 articles
49
Accidents
Canada: Authorized Moderna's vaccine trial and restricted travel from DRC, contributing to global response.
Moderna: Authorized to begin Phase 1 trials for a Bundibugyo vaccine, using mRNA technology. Potential for significant revenue if successful.
Aug 01, 2026 · 295 articles
45
Accidents
Canada: Approved Moderna's vaccine trial and imposed entry restrictions on travelers from DRC. Its regulatory support is important for vaccine development.
Moderna: Developed an mRNA-based Bundibugyo vaccine candidate, with Phase 1 trials starting in Canada. Its mRNA platform could offer a rapid response to emerging outbreaks.
Mar 09, 2018 · 543 articles
45
Regulatory
Canada: Canada is reviewing the vaccine, potentially broadening its availability.
Moderna: Moderna received its fourth FDA-approved product and first mRNA flu vaccine, boosting its commercial prospects and validating its mRNA platform.
Aug 05, 2026 · 105 articles
35
Business
Canada: Canada is among the top countries for immigrant founders of US billion-dollar companies.
Moderna: Moderna is an immigrant-founded unicorn company that has gone public since 2016.
Jun 04, 2026 · 6 articles
32
Tech
Canada: Canada is a potential market, with melanoma incidence and patient advocacy groups responding positively.
Moderna: Moderna is the developer of the mRNA vaccine and the primary beneficiary, with its stock surging over 120% and market cap increasing by nearly $40 billion. The trial success validates its mRNA platform beyond COVID-19 and could lead to a new revenue stream.
Aug 19, 2026 · 102 articles
17
Accidents
Canada: Canada is mentioned as a co-host of the World Cup, which the Democratic Republic of the Congo football team cancelled its training camp for due to the Ebola outbreak.
Moderna: Moderna is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
0
Regulatory
Feb 18, 2026 · 9 articles
0
Regulatory
Feb 10, 2026 · 6 articles
75 Moderna authorized to start trial CanadaDR Congo Ebola outbreak...
70 Canada approved clinical trials ModernaDRC Ebola outbreak spreads...
40 Moderna submitted regulatory applications CanadaFDA Approves Moderna's...
ERGEN INTELLIGENCE
Explore this relationship live

Track how Canada and Moderna interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.